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The psychological construct of ‘ikigai’ reflects the sense of having a ‘reason for living’ and has been 
associated with various positive health-related outcomes. This proposal presents an English translation of the 
Ikigai-9, empirically explores the manifestation of ikigai in the United Kingdom, and outlines its associations 
with facets of well-being. 
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Methodology Cross sectional, correlational design with factor analysis 
Study Duration Estimated duration for the main protocol (i.e., first to last participant sampled) was one 
month 
Study Centre University of Derby, Derby, UK 
Objectives Primary Objective: 
Translate and validate the Ikigai-9 for use in English-speaking populations 
 
Secondary Objective: 
Delineate associations between ikigai and state measures of mental wellbeing, depression, 
anxiety, and stress 
Number of 
Participants 




- Male and female participants aged 18 years and above  
- UK nationality 
- Fluent in English 
 
Exclusion Criteria: 




Hierarchical multiple regression using ikigai to predict state measures of mental 





The primary objective is to translate the Ikigai-9 (Imai, 
Osada, & Nishi, 2012) into English and to validate it 
within a cohort derived from the United Kingdom (UK). 
 
Background: 
The formal definition of ikigai refers to a “joy and a 
sense of well-being from being alive” and “realizing the 
value of being alive” (Toshirō, Skrzypczak, & 
Snoewden, 2003, p. 459). In Japanese culture, having a 
sense of ‘life worth living’ (i.e., ikigai) is considered an 
indicator of well-being, which amalgamates 
psychological well-being and consciousness about 
motivations for living (Mori et al., 2017). Previously, 
ikigai has been associated with lower risk of functional 
disability (Mori et al., 2017), longevity (Tanno et al., 
2009), and reduced impact on caregiver burden 
(Okamoto & Harasawa, 2009) in Japanese populations. 
However, to date, no published research has explored 
the role of ikigai in Western populations. In modern 
Western literature, the concept of ikigai has grown in 
significance within the fields of positive psychology 
and well-being (Buettner, 2017; García & Miralles, 
2017), however no study has quantitatively examined 
this concept in English-speaking populations, partly 
because of the absence of an appropriate measurement 
tool in English. Previously, use of the Japanese Ikigai-9 
scale has only been empirically used in a single study 
(within an elderly sample). As such, in order to achieve 
our aims, we seek to translate (including back-
translation) the Ikigai-9 into English and investigate its 
validity in a more general population (e.g., male and 
female adults) within the UK. Moreover, as the Ikigai-
9 has never-before been investigated alongside other 
more general well-being measures, this study will seek 
to delineate baseline associations between ikigai and 
mental well-being, depression, anxiety, and stress.    
 
Objectives: 
1. Translate the Ikigai-9 into English (including 
back-translation) 
2. Validate the Ikigai-9 (Eng) in an English-
speaking sample 
3. Delineate associations between ikigai and state 
measures of mental wellbeing, depression, 
anxiety, and stress 
 
Duration of the Study: 
Through use of the participant crowdsourcing website 
Prolific (see ‘Recruitment Methods’), enrolment and 
data collection for this study is estimated to take no 
longer than one month to complete. However, 
enrolment will remain open until the minimum sample 
size (n = 368) is met. The duration of this study for each 





This cross-sectional study will involve ~368 
participants completing a battery of questionnaires at a 
single timepoint. Demographics (i.e., age, sex, 
nationality) and state-measures of ikigai, mental well-
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being, depression, anxiety, and stress will be measured 
online using survey software Qualtrics. 
 
Study Population, Selection Criteria, and Sample Size 
Justification 
All participants will provide full informed consent, as 
indicated by a button press on the first and final pages 
of the survey. Participants will be males and females 
aged 18 years and over, of UK nationality, and fluent in 
English. Participants will be excluded if they have a 
current (i.e., within six-months) diagnosis of 
psychiatric, affective, or neurological disorder, so as not 
to bias data pertaining to mental well-being.  
 
As visualised in Table 1 and Figure 1, an a priori power 
analysis (f2 = .03, α = .05) determined that around 368 
participants were required to have 80% power in the 
planned analyses (G*Power, v3.1). Here, power is 
defined as the likelihood of correctly detecting an effect 
in the event that said effect exists, so a higher power 
level indicates a reduced likelihood of concluding an 
absence of an effect when that effect exists (i.e., Type II 
error). As a function of data being captured at a single 
timepoint, no calculation adjustments have been made 




Power analysis across power levels 
 
 Power (1- β) 
0.70 0.75 0.80 0.85 0.90 0.95 
Sample 
Size 
297 329 368 414 476 576 
Figure 1 




Participants will be identified through the 
crowdsourcing website Prolific (prolific.co), and the 
study survey) will be made available to all members 
who meet the required inclusion criteria. This is an 
automated process determined through member 
responses to a series of questions first answered when 
signing up to the platform. Prolific is thought to 
generate data quality comparable to that obtained via 
face- to-face means (Peer et al., 2017), and members 
who go on to participate in the study will be paid an 
average of £5 per hour; roughly £0.85 for this study (10 
minutes). At the time of writing, there are 80,714 
potential participants to take part in this study, so data 
collection for this purpose is entirely feasible.  
 
Data Collection and Study Schedule 
Individual data will be collected at a single time point, 
with all data expected to be collected within a period of 
one month. On the first two pages of the survey, 
participants will be presented with all study information 
and will be asked to affirm their consent. On subsequent 
pages (not accessible unless consent has been given), 
participants will be asked to answer brief demographic 
questions (i.e., age, sex, nationality) prior to completing 
three short psychometric measures, namely the nine-
item English version of Imai et al.’s (2012) Ikigai-9, the 
seven-item Short Warwick-Edinburgh Mental Well-
being Scale (SWEMWBS; Stewart-Brown et al., 2009), 
and the 21-item Depression Anxiety Stress Scales 
(DASS-21; Lovibond & Lovibond, 1995) – all of which 
the research team have expertise and qualification in 
distribution and interpretation. Each scale will be 
presented, along with completion instructions, on a 
separate page, and the study will close with a debrief 
page where participants will be asked to re-affirm their 
consent. Data will be maintained for as long as 
necessary (with identifiable data destroyed after two 
weeks) for the purpose of transparent and open science, 
with the exception of data obtained from participants 
who withdraw from the study either during or following 
participation (up to a period of two weeks). In such 
cases, any associated data will be permanently deleted.  
 
Expected Outcomes 
The research team expects the English translation of the 
Ikigai-9 to hold a similar factor structure in UK 
responders to that observed in a Japanese cohort 
elsewhere (Imai et al., 2012). Moreover, as existing 
literature suggests, it is expected that scores on the 
Ikigai-9 will be positively associated with self-reported 
mental wellbeing and negatively associated with state 
depression, stress, and anxiety.  
 
Adverse Events 
There is no expectation of any adverse outcomes or 
effects on participants as a direct result of this study. 
Nevertheless, the research team acknowledges that 
questions asked within this study relate to mental 
wellbeing, which has the potential to lead participants 
to ruminate on their own mental wellbeing. As such, 
participants will be signposted to UK-based mental 
health charities (e.g., Mind) and their healthcare 
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providers (e.g., general practitioners) at both the point 
of consent and debrief. Participants are neither asked 
nor expected to disclose any subsequent 




Reasons for Withdrawal  
Potential participants identified via Prolific are under no 
obligation to take part in the study. Participants who do 
consent to take part can withdraw their consent either 
during the study (by closing their web browser or by not 
affirming consent at the point of debrief) or after taking 
part in the study up to two weeks prior (by e-mailing the 
Principal Investigator (PI) using the provided e-mail 
address with their Prolific ID, an ID associated with 
their specific data entry). No reason for this withdrawal 
will be asked or expected to be given. Participation in 
the study may be automatically terminated (via 
Qualtrics settings) should the participant decline to give 
consent. No adverse events will be measurable during 
the study due to the data being collected remotely and 
not in person. As such, no considerations are made for 
adverse events that lead to participant termination up to 
two weeks following participation.  
 
Handling of Participant Withdrawal 
As mentioned above, participants may withdraw at any 
time during the study and up to two weeks afterwards, 
and participants will not be asked to give a reason for 
their withdrawal. Participants who withdraw from the 
study will not be replaced, so long as the study sample 
does not fall under 0.75 power (n = 329); in such 
instances, further participants will be sampled.  
 
Premature Termination or Suspension of Study 
Although not expected, the study may be temporarily 
suspended or prematurely terminated if there is 
sufficient and reasonable cause to do so. In such 
instances, the PI will directly notify the research ethics 
committee that approved the study in writing, providing 
reason(s) for the suspension and/or termination of the 
study. Potential circumstances which might result in 
temporary suspension or premature termination include 
[1] unexpected, significant, or unacceptable risk to 
participants, [2] determination of futility, and [3] 
unexpected detriment to the secure maintenance and 
quality of data. The study may resume once any 
concerns have been addressed and satisfy the needs of 
both the research team and research ethics committee. 
Statistical Analysis Plan: 
All analyses for this study have been determined a 
priori. To determine construct validity of the Ikigai-9 
(the English version), confirmatory factor analysis will 
be run on the composite dataset, and the root mean 
square error of approximation (RMSEA), comparative 
fit index (CFI), and Tucker-Lewis index (TLI) will be 
reported according to cut-off values provided by Hu and 
Bentler (1999). If the two-factor structure delineated in 
Imai et al. (2012) is not confirmed, principal axis factor 
analysis will be conducted to determine a better fit.  
 
To determine concurrent validity, four hierarchical 
multiple regression analyses will be conducted 
(whereby the dependant variables will be scores on 
well-being, depression, anxiety, and stress). In each 
analysis, age and sex (0 = male, 1 = female) will be 
entered at step 1 and ikigai will be entered at step 2. 
Alongside these analyses, assumption testing will be 
carried out with bi-variate correlations. If post-hoc 
analyses are conducted, these will be reported as such 
in any resulting manuscript.   
 
Assessment of Safety: 
Although not expected, this study will follow standard 
definitions of adverse events (AEs) and report any AEs 
to the research ethics committee for up to two weeks 
after the final participant has taken part in the study.  
 
Adverse Events are defined as any unanticipated 
physical or mental well-being occurrence, regardless of 
its relationship to the study, such as self-reported stress 
or anxiety following participation in the study that may 
or may not require further intervention.  
 
Serious Adverse Events are defined as AEs that are 
considered serious, such as those requiring 
hospitalisation, are life-threatening, or result in death. 
 
In the event of any AE being acknowledged by the 
research team, the PI will assign a level of severity to 
the event (Mild, Moderate, Severe) and assess the 
likelihood that said AE is related to the study protocols 
(Definitely, Probably, Possibly, Unrelated). These 








Mild Requires no or minimal intervention; 
not impacting the participant  
Moderate Moderate inconvenience to the 
participant; potentially interfering with 
day-to-day activities of the participant  
Severe Severe inconvenience to the participant 
that may require intervention; severely 
interfering with day-to-day activities of 
the participant and may be life-
threatening 
  
Definitely The relationship between the AE and 
the study protocol can be clearly 
established 
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Probably The relationship between the AE and 
the study protocol cannot be clearly 
established, however there is no other 
reason or event which could clearly 
explain the occurrence of the AE 
Possibly The relationship between the AE and 
the study protocol cannot be clearly 
established, but the definite lack of a 
relationship cannot be concluded 
Unrelated There is no relationship between the AE 
and the study protocol.  
 
Prior to gaining ethical consent to conduct the study 
from the research ethics committee, only a single 
possible risk has been identified by the research team: 
that of ‘consciousness of poor mental wellbeing’ after 
being presented with questions asking them to reflect on 
their own mental wellbeing (including questions asking 
about stress, anxiety, and depression). This risk was 
identified as being mild (as opposed to moderate or 
severe) and will be protected against within the study by 
two methods. First, it will be made clear to the potential 
participants within the study information that questions 
about mental wellbeing will be asked, so as to allow 
opportunity to refuse consent. Second, participants will 
be signposted to charity and wellbeing services at both 
the point of consent and debrief, allowing an 
opportunity for participants to access support even 
without taking part in the research.  
 
Data Monitoring: 
The PI will be responsible to ensure the study is 
conducted in accordance with the protocol, standards of 
Good Clinical Practice (GCP), and applicable 
regulatory requirements as defined by the British 
Psychological Society (BPS), and that the data recorded 
is valid and appropriately stored and maintained. To this 
end, data collection (via Prolific) will be collected in 
three stages to ensure quality: Stage 1 being a short pilot 
of five participants to check data quality and difficulties 
arising from the usability of the questionnaire, and 
Stages 2 and 3 being the collection of male and female 
responses separately to ensure a good distribution of 
data across sexes. Due to the nature of data collection 
(i.e., anonymous participants over a single time point), 
it will not be possible to follow-up on any incomplete 
data, nor will it be possible to verify the accuracy of 
submitted data. However, the questionnaire pack is 
devised in a manner to minimise errors (e.g., clear 
instructions) and uses a ‘request response’ function in 
order to remind participants to complete all sections of 
the survey should any question be missed. To comply 
with ethical standards, although this function is enabled, 
participants will be able to subsequently skip said item 
should they not wish to complete it.  
 
No external data monitor will be appointed to ensure the 
study complies with GCP or BPS standards; however, 
data and analysis scripts will be made freely and openly 
available to those wishing to replicate our findings (via 
the Open Science Framework or ResearchGate).  
 
Data Handling and Record Keeping: 
The collection of personal data from the participants 
will be limited to the number and type required to 
perform the planned analyses and in order to achieve the 
aims of the research. Data will be maintained on 
Qualtrics (survey software and secure database) until 
the required sample size has been collected, at which 
point the data will be exported into an Excel or SPSS 
file format (password protected), backed-up, and 
subsequently deleted from Qualtrics. Any unique 
identifiers collected within the dataset will be 
permanently deleted two weeks after the final 
participant completes the study, and there will be no 
hard copies of the data generated or maintained. Fully 
anonymised data will be used for data analysis, which 
will be led by the PI (DF). 
 
As part of the publication process, a permanent open-
access version of the subscale-level data (i.e., no 
individual participant responses per item) will be made 
available on the Open Science Framework. Where 
possible, a link to such files will be included within the 
manuscript publication for the purpose of transparency 
and scrutiny. At no point will participants be 
identifiable from this dataset.  
 
Research Ethics Committee: 
The protocol, participant-facing documents, and 
questionnaire pack will be submitted to a local research 
ethics committee for review, feedback, and approval. 
Approval of all documents is required before any 
participant enters into the study. Any amendment to the 
protocol will undergo further review and approval by 
the research ethics committee before the changes are 
implemented to the study; however, as participation is 
anonymous and participants are not requested to 
provide contact details, re-consent to take part in the 
study will not be possible, and as such any data obtained 
prior to amendments will only be treated in accordance 




After clicking on the study link and being presented 
with the study information sheet (including all 
information about the study, methods of withdrawal, 
information about data management, and contact details 
of the study team and signposted services), participants 
will then be presented with the consent form on the 
subsequent page of the online survey. To take part in the 
study, participants must affirm their consent and 
understanding of the aforementioned information via a 
button press; refusal to do this will lead the Qualtrics 
software to terminate their participation with a ‘thank 
you’ message. Participants will not have to sign, date, 
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or present any additional identifiable information. 
Following a debrief of the study, and in accordance with 
guidelines for internet mediated research (BPS, 2017), 
participants will be asked to re-affirm their consent as a 
means of mitigating against the usage of data from 
participants who prematurely exited the study and/or 
those who no longer wish for their data to be used after 
completing the study.  
 
Protocol Deviation: 
Protocol deviations are defined as any deviation from 
the ethically-approved study protocol and can be 
attributed to either the research team or study 
participants. However, as the nature of the study makes 
it improbable that participants could generate protocol 
deviations, a research team-related example of a 
protocol deviation for this study might include the use 
and storage of data in an unapproved manner. Any 
protocol deviation will be made aware to the research 
team at the earliest availability and corrective measures 
will be actioned if appropriate. Causes, actions, and 
results of any protocol deviations will be signalled to 
the research ethics committee in writing at the first 
available opportunity.  
 
Publication and Data Sharing Policy: 
It is the intention of the research team to publish any 
and all findings of this study in written (e.g., posters, 
journal publications, blog posts) and verbal (e.g., 
conference paper) form. The research team might also 
use findings of this study as a base for future research 
submissions and/or grant applications. At all stages, 
individual participant responses and associating 
identifiable information will be kept confidential, and 
only group-level analyses will be presented/published. 
In accordance with emerging trends in open science, 
anonymised raw data and pre-print manuscripts will be 
made openly available. 
 
Study Personnel and Roles: 
Table 3 documents the members of the research team 
and their associated responsibilities throughout the 




Outline of research team personnel and associated 
project roles 
 
Personnel Role Responsibilities 
Dean Fido Principal 
Investigator 






Study design; Data collection; 






Manuscript drafting and final 
review 
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